A chemical compound derived from vitamin A prevents cancer from forming and is being developed by the National Cancer Institute as a daily preventive pill. The compound, which still faces several rounds of clinical trials, successfully stopped normal cells from turning into cancer cells and inhibited the ability of tumors to grow and form blood vessels. If successful tests continue, researchers eventually hope to create a daily pill that would be taken as a cancer preventive.